We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
+15.25%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
–
AUM
$111M
AUM Growth
-$6.92M
Cap. Flow
-$15.7M
Cap. Flow %
-14.1%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
DYN icon
Dyne Therapeutics
DYN
+$8.48M
2
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$7.06M
3
QTTB icon
Q32 Bio
QTTB
+$169K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
1
Dyne Therapeutics
DYN
$4.24B
$28.2M 25.3%
2,220,034
-740,012
-25% -$8.48M
KNTE
2
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$26.4M 23.68%
2,207,772
-539,661
-20% -$7.06M
ALLO icon
3
Allogene Therapeutics
ALLO
$604M
$19.4M 17.43%
1,798,163
– –
CNTA
4
DELISTED
Centessa Pharmaceuticals
CNTA
$15.8M 14.18%
3,931,818
– –
KRON
5
DELISTED
Kronos Bio
KRON
$9.26M 8.31%
2,765,314
– –
PRAX icon
6
Praxis Precision Medicines
PRAX
$8.8B
$6.67M 5.99%
195,955
– –
LIAN
7
DELISTED
LianBio American Depositary Shares
LIAN
$4.56M 4.1%
2,282,084
– –
QTTB icon
8
Q32 Bio
QTTB
$452M
$1.12M 1.01%
38,683
-4,142
-10% -$169K

Similar funds

NC
Nucleo Capital Sao Paulo, Sp, Brazil $29.1M AUM 59.16% 1-Year Est. Return
PIM
Pinnacle Investment Management Hong Kong $28.9M AUM 32% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
RE
ROB Exploration New York $27.3M AUM 13.99% 1-Year Est. Return
VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
BCA
Burren Capital Advisors Gibraltar $33M AUM 47.67% 1-Year Est. Return
VCM
Vector Capital Management San Francisco, California $24.4M AUM 14.95% 1-Year Est. Return

Vida Ventures Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Vida Ventures Advisors held 8 positions worth $111M, down 5.8% from $118M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vida Ventures Advisors withdrew a net $15.7M in Q3 2022, reducing 3 holdings. Its largest reduction was Dyne Therapeutics, cutting an estimated $8.48M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors's biggest Q3 2022 reduction was Dyne Therapeutics, cutting an estimated $8.48M.
  • Vida Ventures Advisors's ten largest holdings make up 100% of its $111M portfolio in Q3 2022.
  • Vida Ventures Advisors opened 0 new positions and closed 0 in Q3 2022.
  • Vida Ventures Advisors's portfolio value fell 5.8% quarter-over-quarter to $111M.

Based on Vida Ventures Advisors's 13F filing for Q3 2022, filed 5 Oct 2022.